Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study
Author(s) -
M. Kojima,
S. Okubo,
Ryuichi Mizubayashi,
Naoki Isaka,
H. Machida,
Shinya Okamoto,
Hiroko HIROTA,
Masahiro Takeuchi,
Tsuyoshi Kato,
Kaname Nakatani,
Osamu Mizuno,
Koichi Miyagawa,
Keitaro Makino,
Takanori Okura,
Yasuaki Dohi,
Masaaki Ito,
Go Kimura
Publication year - 2013
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gft034
Subject(s) - medicine , amlodipine , albuminuria , urology , olmesartan , diuretic , creatinine , blood pressure , thiazide , endocrinology , hydrochlorothiazide , renal function
A thiazide diuretic used in combination with benazepril is superior to amlodipine plus benazepril in reducing albuminuria in hypertensive patients with diabetes. However, calcium channel blockers have diverse characteristics. Thus, we investigated whether combining an angiotensin receptor blocker with either azelnidipine or a thiazide diuretic produced similar reductions in albuminuria in hypertensive diabetic patients for the same levels of blood pressure achieved.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom